Literature DB >> 6674812

Genomic organization of Trypanosoma brucei variant antigen gene families in sequential parasitemias.

M Parsons, R G Nelson, G Newport, M Milhausen, K Stuart, N Agabian.   

Abstract

cDNA libraries were made from mRNA purified from each of seven sequentially isolated variant antigen types (VATs) of the IsTat 1 serodeme. Plasmids containing variant surface glycoprotein (VSG) sequences corresponding to each of the isolates were used in Southern analyses to examine the genomic organization of VSG nucleotide sequences. In most cases, cells expressing a given VSG were shown to have an extra copy of the corresponding VSG gene. In one case an expression-linked copy (ELC) was not detectable. VSG gene rearrangements not obviously correlated with the expression of homologous sequences were detected in four of six VSG gene families. Thus, even cDNAs which detected an ELC revealed additional genomic reorganization in regions flanking VSG sequences. The cells used to initiate the chronic infection expressed the same VSG as those isolated from the first parasitemia. The extent of genomic rearrangement observed between these two sequentially derived populations was comparable to that observed between any of the other serially derived VATs. Thus, within a short period of time and in the absence of detectable antigenic variation, the amount of genetic flux in sequences associated with VSG genes can be substantial.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6674812     DOI: 10.1016/0166-6851(83)90101-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  10 in total

Review 1.  Molecular biology of trypanosome antigenic variation.

Authors:  J E Donelson; A C Rice-Ficht
Journal:  Microbiol Rev       Date:  1985-06

2.  (TAA)n within sequences flanking several intrachromosomal variant surface glycoprotein genes in Trypanosoma brucei.

Authors:  R Aline; G MacDonald; E Brown; J Allison; P Myler; V Rothwell; K Stuart
Journal:  Nucleic Acids Res       Date:  1985-05-10       Impact factor: 16.971

3.  A 5' spliced leader is added in trans to both alpha- and beta-tubulin transcripts in Trypanosoma brucei.

Authors:  S Sather; N Agabian
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  Variant antigen genes of Trypanosoma brucei: genomic alteration of a spliced leader orphon and retention of expression-linked copies during differentiation.

Authors:  M Parsons; R G Nelson; K Stuart; N Agabian
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Characterization of the genes specifying two metacyclic variable antigen types in Trypanosoma brucei rhodesiense.

Authors:  M J Lenardo; A C Rice-Ficht; G Kelly; K M Esser; J E Donelson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  The IsTat 1.3 VSG multigene family in Trypanosoma brucei: retention of the expression linked copy through multiple antigenic switches.

Authors:  J Allison; V Rothwell; G Newport; N Agabian; K Stuart
Journal:  Nucleic Acids Res       Date:  1984-12-11       Impact factor: 16.971

7.  The trypanosome spliced leader small RNA gene family: stage-specific modification of one of several similar dispersed genes.

Authors:  M Parsons; R G Nelson; N Agabian
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

8.  The 85-kd surface antigen gene of Trypanosoma cruzi is telomeric and a member of a multigene family.

Authors:  D S Peterson; D L Fouts; J E Manning
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

9.  Trypanosome mRNAs share a common 5' spliced leader sequence.

Authors:  M Parsons; R G Nelson; K P Watkins; N Agabian
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

10.  Identification of a small RNA containing the trypanosome spliced leader: a donor of shared 5' sequences of trypanosomatid mRNAs?

Authors:  M Milhausen; R G Nelson; S Sather; M Selkirk; N Agabian
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.